|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Vosoritide>> Market Analysis Reports |
Market Analysis Reports of Vosoritide |
|
Achondroplasia (Musculoskeletal) - Drugs In Development, 2021 Achondroplasia (Musculoskeletal) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Drugs In Development, 2021, provides an overview of the Achondroplasia ( ... Achondroplasia - Pipeline Review, H2 2020 Achondroplasia - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Pipeline Review, H2 2020, provides an overview of the Achondroplasia (Musculoskeletal Disorders) pipeline ... Achondroplasia - Pipeline Review, H1 2020 Achondroplasia - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Pipeline Review, H1 2020, provides an overview of the Achondroplasia (Musculoskeletal Disorders) pipeline ... Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Achondroplasia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Achondroplasia - Drugs In Development, 2022, provides ... Achondroplasia Market - A Global and Regional Analysis: Focus on Country, and Regional Markets - Analysis and Forecast, 2025-2035 ... Advancements in therapies such as Voxzog%li%(vosoritide), a groundbreaking treatment that ... of treatments such as Voxzog%li%(vosoritide), a synthetic C-type natriuretic ... therapies. The development of Voxzog%li%(vosoritide), a therapy designed t%li%stimulate ... Global Skeletal Dysplasia Market Size Study & Forecast, by Type (X-linked hypophosphatemia, Hypophosphatasia, Achondroplasia, Fibrodysplasia ossificans progressive, Multiple osteochondromas, Others), by Treatment (Medication, Surgery, Others) and Regional Analysis, 2022-2029 ... Drug Administration (FDA) granted VOXZOGO (vosoritide) for Injection accelerated approval, according ... Skeletal Dysplasia Market Size, Share & Trends Analysis Report By Type (Achondroplasia, X-linked Hypophosphatemia, Hypophosphatasia), By Treatment, By Symptom, By Region, And Segment Forecasts, 2025 - 2030 ... spontaneous mutations in the FGFR3 gene. Vosoritide by BioMarin targets inhibition of the FGFR3 ... |